These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 8104554

  • 1. Dopamine receptor pharmacology.
    Seeman P, Van Tol HH.
    Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):602-8. PubMed ID: 8104554
    [Abstract] [Full Text] [Related]

  • 2. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

  • 3. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine.
    Van Tol HH, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, Civelli O.
    Nature; 1991 Apr 18; 350(6319):610-4. PubMed ID: 1840645
    [Abstract] [Full Text] [Related]

  • 4. Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata.
    Seeman P, Guan HC, Van Tol HH, Niznik HB.
    Synapse; 1993 Aug 18; 14(4):247-53. PubMed ID: 8248849
    [Abstract] [Full Text] [Related]

  • 5. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4.
    Seeman P.
    Neuropsychopharmacology; 1992 Dec 18; 7(4):261-84. PubMed ID: 1362057
    [Abstract] [Full Text] [Related]

  • 6. Atypical antipsychotics: mechanism of action.
    Seeman P.
    Can J Psychiatry; 2002 Feb 18; 47(1):27-38. PubMed ID: 11873706
    [Abstract] [Full Text] [Related]

  • 7. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors.
    Seeman P, Corbett R, Van Tol HH.
    Neuropsychopharmacology; 1997 Feb 18; 16(2):93-110; discussion 111-35. PubMed ID: 9015795
    [Abstract] [Full Text] [Related]

  • 8. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs.
    Lidow MS, Goldman-Rakic PS.
    J Pharmacol Exp Ther; 1997 Nov 18; 283(2):939-46. PubMed ID: 9353417
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic receptor-blocking concentrations of neuroleptics.
    Seeman P.
    Int Clin Psychopharmacol; 1995 Sep 18; 10 Suppl 3():5-13. PubMed ID: 8866760
    [Abstract] [Full Text] [Related]

  • 10. Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist.
    Burstein ES, Ma J, Wong S, Gao Y, Pham E, Knapp AE, Nash NR, Olsson R, Davis RE, Hacksell U, Weiner DM, Brann MR.
    J Pharmacol Exp Ther; 2005 Dec 18; 315(3):1278-87. PubMed ID: 16135699
    [Abstract] [Full Text] [Related]

  • 11. Dopamine D4 receptors elevated in schizophrenia.
    Seeman P, Guan HC, Van Tol HH.
    Nature; 1993 Sep 30; 365(6445):441-5. PubMed ID: 8413587
    [Abstract] [Full Text] [Related]

  • 12. Dopamine receptor genes: new tools for molecular psychiatry.
    Niznik HB, Van Tol HH.
    J Psychiatry Neurosci; 1992 Oct 30; 17(4):158-80. PubMed ID: 1450188
    [Abstract] [Full Text] [Related]

  • 13. Role of serotonin in the action of atypical antipsychotic drugs.
    Meltzer HY.
    Clin Neurosci; 1995 Oct 30; 3(2):64-75. PubMed ID: 7583621
    [Abstract] [Full Text] [Related]

  • 14. [Clinical psychopharmacology: the example of clozapine (Leponex)].
    Péré JJ.
    Encephale; 1995 Jun 30; 21 Spec No 3():9-12. PubMed ID: 7628347
    [Abstract] [Full Text] [Related]

  • 15. Dopamine receptors and antipsychotic drug response.
    Sunahara RK, Seeman P, Van Tol HH, Niznik HB.
    Br J Psychiatry Suppl; 1993 Dec 30; (22):31-8. PubMed ID: 7906523
    [Abstract] [Full Text] [Related]

  • 16. The peripheral dopaminergic system: morphological analysis, functional and clinical applications.
    Amenta F, Ricci A, Tayebati SK, Zaccheo D.
    Ital J Anat Embryol; 2002 Dec 30; 107(3):145-67. PubMed ID: 12437142
    [Abstract] [Full Text] [Related]

  • 17. Dopamine receptors--the present state of research and perspectives.
    Wolfarth S, Ossowska K.
    Pol J Pharmacol; 1995 Dec 30; 47(3):207-18. PubMed ID: 8714754
    [Abstract] [Full Text] [Related]

  • 18. Heterodimerization of dopamine receptors: new insights into functional and therapeutic significance.
    Maggio R, Aloisi G, Silvano E, Rossi M, Millan MJ.
    Parkinsonism Relat Disord; 2009 Dec 30; 15 Suppl 4():S2-7. PubMed ID: 20123551
    [Abstract] [Full Text] [Related]

  • 19. Dopamine receptors and schizophrenia.
    Reynolds GP.
    Biochem Soc Trans; 1996 Feb 30; 24(1):202-5. PubMed ID: 8674664
    [No Abstract] [Full Text] [Related]

  • 20. Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors.
    Malmberg A, Jackson DM, Eriksson A, Mohell N.
    Mol Pharmacol; 1993 May 30; 43(5):749-54. PubMed ID: 8099194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.